Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 22
Filter
1.
Ear Nose Throat J ; 102(9): NP457-NP465, 2023 Sep.
Article in English | MEDLINE | ID: mdl-34082610

ABSTRACT

OBJECTIVE: The aim of this study was to assess the long-term effectiveness of quantic molecular resonance (QMR) in the treatment of inferior turbinate hypertrophy (ITH) in allergic and nonallergic rhinitis refractory to medical therapy. METHODS: This study enrolled 281 patients, 160 males (56.9%) and 121 females (43.1%), mean age 37.8 ± 4.1 years, range 18 to 71. Fifty-four patients have been lost to follow up and have been therefore excluded from the final analysis. Based on skin prick test results, 69 patients were considered allergic (group A) and 158 nonallergic (group B). All subjects underwent before surgery (T0) and 3 (T1), 12 (T2), 24 (T3), and 36 months (T4) after QMR treatment to: 4-phase rhinomanometric examination, nasal endoscopy evaluation, and visual analogue scale to quantify the subjective feelings about nasal obstruction. RESULTS: Subjective and objective parameters showed statistically significant improvement in both groups. Group B parameters not changed during follow-up, while group A showed significant worsening between T1 and subsequent assessments. T4 outcome indicates a better result in nonallergic patients. CONCLUSIONS: In accordance with the literature, our preliminary data validate QMR treatment as a successful therapeutic option for nasal obstruction due to ITH. Nonallergic patients had a very good T4 outcome. Allergic patients showed a worsening trend after 1 year probably due to other causes.


Subject(s)
Nasal Obstruction , Rhinitis, Allergic , Rhinitis , Male , Female , Humans , Adolescent , Young Adult , Adult , Middle Aged , Aged , Rhinitis/complications , Follow-Up Studies , Turbinates/surgery , Nasal Obstruction/surgery , Hypertrophy/surgery , Treatment Outcome , Rhinitis, Allergic/drug therapy , Rhinitis, Allergic/complications
2.
Rev Recent Clin Trials ; 17(1): 46-52, 2022.
Article in English | MEDLINE | ID: mdl-34514992

ABSTRACT

BACKGROUND: Deep Neck Infections (DNIs) spread along fascial planes and involve neck spaces. Recently, their incidence has decreased due to the introduction of antibiotics; nevertheless, complications related to DNIs are often life-threatening. OBJECTIVE: The purpose of this article is focused on the identification of predisposing factors of these complications, as well as on the development of a reliable therapeutic algorithm. METHODS: Sixty patients with DNIs were enrolled from 2006 to 2019 for a retrospective study. The exclusion criteria for the present study were cellulitis, small abscesses responding to empiric or specific antibiotic therapy, or involvement of only one deep neck space. During the analysis, the following parameters of interest have been evaluated: gender, age, site of origin, pathways of spread, comorbidities, clinical features, bacteriology data, type of surgical approach required, complications, duration of hospitalization and mortality rate. On admission, microbial swab analysis was performed. RESULTS: Diabetes Mellitus (DM), Chronic Obstructive Pulmonary Disease (COPD), iron deficiency anemia and the involvement of multiple spaces have been associated with a significantly higher risk of developing complications. Most of our patients had polymicrobial infections. All patients underwent surgical drainage. The complication rate had occurred in 56.6% of patients, while death in 18.3%. CONCLUSION: DNIs represent a medical and surgical emergency with potentially serious complications; thus, avoidance of diagnostic delay is mandatory. Our preliminary data suggest the importance of evaluating the extent of infections because the involvement of multiple spaces requires timely surgery due to the higher risk of complications and mortality.


Subject(s)
Delayed Diagnosis , Neck , Abscess/diagnosis , Abscess/etiology , Abscess/therapy , Algorithms , Anti-Bacterial Agents/therapeutic use , Delayed Diagnosis/adverse effects , Humans , Neck/microbiology , Neck/surgery , Retrospective Studies
3.
Acta Otorhinolaryngol Ital ; 41(3): 255-262, 2021 Jun.
Article in English | MEDLINE | ID: mdl-34264919

ABSTRACT

The most common form of posterior canal benign paroxysmal positional vertigo (BPPV) is characterised by positional, paroxysmal, upbeat nystagmus, with a torsional component beating towards the downward ear. Rarer variants have been reported, putatively due to either the position of otoconia in the canal or anatomic variations of the semicircular canals. The most frequent less common form is apogeotropic posterior canal BPPV, in which the positional nystagmus is downbeat and torsional apogeotropic. In this form, the main problems are differential diagnosis with central mimics of BPPV and identification of the affected canal and its side. The authors propose a new subtype of apogeotropic posterior canal BPPV hypothesising the localization of otoconia in the ampullary tract of the affected canal, which might explain the modality of the conversion in typical posterior canal BPPV which they observed in some of these cases. If nystagmus of the less common forms of posterior canal BPPV is explicable through purely peripheral mechanisms, these forms should no longer be defined as "atypical" but, in a less demanding way, as "less common" variants, which must be recognised by any expert otoneurologist.^ieng


La forma più comune di vertigine parossistica posizionale benigna (VPPB) del canale posteriore è caratterizzata da nistagmo posizionale, parossistico, verticale in alto, con componente torsionale verso l'orecchio posizionato più in basso. Varianti meno comuni sono presumibilmente dovute alla posizione degli otoliti nel canale o a variazioni anatomiche dei canali semicircolari. La forma rara più frequente è quella apogeotropa, in cui il nistagmo posizionale batte verso il basso e la componente torsionale batte in opposizione all'orecchio malato. In questa forma, i problemi principali sono la diagnosi differenziale con le forme centrali di vertigine posizionale e l'identificazione del canale e lato interessati.Gli autori propongono un nuovo sottotipo di VPPB apogeotropa del canale posteriore, ipotizzando la localizzazione degli otoconi nel tratto ampollare del canale interessato, il che potrebbe spiegare la modalità della conversione in forma tipica del canale posteriore osservata in alcuni di questi casi. Se il nistagmo delle forme meno comuni di VPPB del canale posteriore è spiegabile attraverso meccanismi periferici, queste forme non dovrebbero più essere definite come "atipiche" ma, in modo meno impegnativo, come varianti "meno comuni" la cui conoscenza è richiesta all'Otoneurologo esperto.


Subject(s)
Benign Paroxysmal Positional Vertigo , Nystagmus, Pathologic , Benign Paroxysmal Positional Vertigo/diagnosis , Humans , Semicircular Canals
4.
Clin Case Rep ; 9(4): 2094-2098, 2021 Apr.
Article in English | MEDLINE | ID: mdl-33821187

ABSTRACT

Laryngectomized patients showed an unconventional response to SARS-CoV-2 viral infection. Here, we describe five different patient cases along with our interpretation of the phenomena and suggestions for their safe management.

5.
Acta Otorhinolaryngol Ital ; 41(1): 69-76, 2021 Feb.
Article in English | MEDLINE | ID: mdl-33746225

ABSTRACT

OBJECTIVE: Study the high-frequency vestibulo-oculomotor reflex in posterior canal benign paroxysmal positional vertigo (BPPV) through Video Head Impulse Test (vHIT). METHODS: 150 patients suffering for the first time from posterior canal BPPV were studied. Posterior canal vestibulo ocular reflex (VOR) gain was analysed through stimulations in right anterior-left posterior and left anterior-right posterior planes before treatment, immediately after resolution of the acute stage and one month later. Results were compared with a group of 100 healthy individuals. RESULTS: No significant difference between the study the control groups was observed, except for normalised asymmetry ratio of the posterior canal which was significantly higher in the study group. VOR gains of both affected posterior canals and contralateral healthy posterior canals were not significantly correlated with the VOR gain of ipsilateral and contralateral anterior canals. CONCLUSIONS: vHIT does not seem to represent an essential tool to study typical posterior canal BPPV in patients affected by this disease for the first time. Different results might be expected in relapsing forms, non-responsive forms, long lasting forms, or atypical variants in which major damage could be provoked by the persistence of otoconia in the canal or by its complete or partial jam.


Subject(s)
Benign Paroxysmal Positional Vertigo , Head Impulse Test , Benign Paroxysmal Positional Vertigo/diagnosis , Humans , Otolithic Membrane , Reflex, Vestibulo-Ocular , Semicircular Canals
6.
Am J Otolaryngol ; 42(3): 102934, 2021.
Article in English | MEDLINE | ID: mdl-33526270

ABSTRACT

Spindle cell larynx carcinoma (SpCC) represents around 3% of laryngeal cancers. It is originated by a single cancer stem cell undergoing epithelial to mesenchymal transition. This explains the aggressiveness, the peculiar resistance to conventional therapy and the frequent relapses. We focused on this particular cancer subset characteristics in patients, in early and advanced stages primarily aiming to define and highlight the differences with Laryngeal Squamous Cell Carcinoma (LSCC) focusing on clinical features, treatments, follow-up and survival in a patient's cohort composed by comparable cases from two subgroups.


Subject(s)
Laryngeal Neoplasms/pathology , Sarcoma/pathology , Adult , Aged , Aged, 80 and over , Antineoplastic Agents/pharmacology , Antineoplastic Agents/therapeutic use , Carcinoma, Squamous Cell/mortality , Carcinoma, Squamous Cell/pathology , Drug Resistance, Neoplasm , Female , Humans , Laryngeal Neoplasms/mortality , Laryngeal Neoplasms/therapy , Male , Middle Aged , Neoplasm Recurrence, Local , Neoplasm Staging , Sarcoma/mortality , Sarcoma/therapy , Survival Rate
7.
J Clin Med ; 10(2)2021 Jan 08.
Article in English | MEDLINE | ID: mdl-33429854

ABSTRACT

Temporal bone fractures are a common lesion of the base of the skull. The diagnosis and management of temporal bone fractures require a multidisciplinary approach. Variable clinical presentations may arise from such fractures, ranging from an asymptomatic course to very serious consequences. The aim of this study was to report our experience with a series of patients with temporal bone fractures and to propose a diagnostic/therapeutic algorithm. This study enrolled 141 patients, 96 (68.1%) males and 45 (31.9%) females, ranging in age from 20 to 60 (average age: 39 ± 4.1 years), with temporal bone fractures who were referred to Cardarelli Hospital between 2006 and 2018. The present paper presents a classification of temporal bone fractures and typical clinical sequelae and provides an illustration of their prognosis and treatment.

8.
Mol Ther Nucleic Acids ; 20: 711-724, 2020 Jun 05.
Article in English | MEDLINE | ID: mdl-32402942

ABSTRACT

Laryngeal cancer (LCa), a neoplasm of the head and neck region, is a leading cause of death worldwide. Surgical intervention remains the mainstay of LCa treatment, but a crucial point is represented by the possible nodal involvement. Therefore, it is urgently needed to develop biomarkers and therapeutic tools able to drive treatment approaches for LCa. In this study, we investigated deregulated microRNAs (miRNAs) in tissues from LCa patients with either lymph node metastases (N+) or not (N-). miRNA expression profiling was performed by a comprehensive PCR array and subsequent validation by RT-qPCR. Results showed a significant decrease of miR-449a expression in N+ compared to N- patients, and miR-133b down-modulation in LCa tissues compared to paired normal ones. Receiver operating characteristic (ROC) curve analysis revealed the potential diagnostic power of miR-133b for LCa detection. According to the validation results, we selected miR-449a for further in vitro studies. Ectopic miR-449a expression in the LCa cell line Hep-2 inhibited invasion and motility in vitro, slowed cell proliferation, and induced the downregulation of Notch1 and Notch2 as direct targets of miR-449a. Collectively, this study provides new promising biomarkers for LCa diagnosis and a new opportunity to use miR-449a for the treatment of nodal metastases in LCa patients.

9.
Chemotherapy ; 64(1): 48-56, 2019.
Article in English | MEDLINE | ID: mdl-31242489

ABSTRACT

INTRODUCTION: Concurrent platinum-based chemoradiation currently represents the standard treatment for advanced head and neck cancer (HNC), but it induces a significant toxicity, in particular among elderly patients. Elderly and unfit patients have been underrepresented in clinical trials and there is a need for tailored guidelines. METHODS: A retrospective review of clinical data of HNC patients treated at the Operative Oncology Unit of the San Giovanni di Dio Hospital in Frattamaggiore (Naples, Italy) was performed. At study entry, a comprehensive assessment including absolute contraindications for cisplatin use, as well as comorbidities, socioeconomic status, BMI, and weight loss, was performed. The treatment included high-dose radiotherapy plus weekly cetuximab (initially at a dose of 400 mg/m2of body surface area and thereafter at 250 mg weekly during the whole radiotherapy). The aim of this study was to evaluate the activity and toxicity of this schedule in a series of patients aged older than 69 years. RESULTS: Between May 30, 2013, and March 30, 2015, sixty-four patients (age range, 69-87 years; median age, 73.7 years; male/female ratio, 46/18) were treated. The overall response rate was 67% in this series of patients. The disease control rate was 76%. Disease progression was recorded in 25% of the patients. The median duration of loco-regional control was 17 months (range, 15.8-17.7 months). PFS was 14.8 months (range, 13.9-15.5 months). The overall survival was 34 months, with a median follow-up of 41.0 months (range, 31.1-36.8 months). The main grade 3/4 adverse events were acne rash in 52% and radiation dermatitis in 32% of the cases. CONCLUSION: Cetuximab plus radiotherapy appears to be feasible and active in elderly patients unsuitable for cisplatin treatment. The treatment was supported by a favorable toxicity profile.


Subject(s)
Antineoplastic Agents/therapeutic use , Carcinoma, Squamous Cell/therapy , Cetuximab/therapeutic use , Cisplatin/therapeutic use , Head and Neck Neoplasms/therapy , Aged , Aged, 80 and over , Carcinoma, Squamous Cell/drug therapy , Carcinoma, Squamous Cell/radiotherapy , Combined Modality Therapy , Female , Head and Neck Neoplasms/drug therapy , Head and Neck Neoplasms/radiotherapy , Humans , Kaplan-Meier Estimate , Male , Neoplasm Staging , Radiation, Ionizing , Retrospective Studies , Treatment Outcome
10.
Oncology ; 95(6): 353-359, 2018.
Article in English | MEDLINE | ID: mdl-30184543

ABSTRACT

OBJECTIVES: This study evaluates maintenance cetuximab administered every 2 weeks (q2w) after chemotherapy plus cetuximab as first-line treatment in a series of patients with head and neck squamous cell cancer and compares the results with those obtained in a historical control group of patients receiving weekly cetuximab. METHODS: After chemotherapy plus cetuximab as first-line treatment, in Group A, 36 patients enrolled from October 2016 to November 2017, received biweekly cetuximab, administered at 500 mg/m2. Group B was a control group of patients treated at our institution from August 2015 to September 2016 and received weekly infusion of cetuximab at 250 mg/m2. RESULTS: Confirmed overall response rates were, respectively, 19% for Group A and 17% for Group B according to intention-to-treat analysis. During the maintenance treatment, median progression-free survival (PFS) and median overall survival (OS) were similar for both groups (PFS, 4.8 and 4.4 months; OS, 9.0 and 7.9 months; in Groups A and B, respectively). The most common adverse events among treated subjects included fatigue, rash, and hypomagnesemia. CONCLUSION: Maintenance therapy with simplified biweekly cetuximab is a convenient, effective, and well-tolerated regimen in patients with recurrent and/or metastatic head and neck squamous cell carcinoma.


Subject(s)
Cetuximab/administration & dosage , Head and Neck Neoplasms/drug therapy , Squamous Cell Carcinoma of Head and Neck/drug therapy , Aged , Antineoplastic Agents, Immunological/administration & dosage , Antineoplastic Agents, Immunological/adverse effects , Cetuximab/adverse effects , Drug Administration Schedule , Female , Humans , Maintenance Chemotherapy , Male , Middle Aged
11.
Oncol Lett ; 16(3): 2783-2788, 2018 Sep.
Article in English | MEDLINE | ID: mdl-30127863

ABSTRACT

Adenoid cystic carcinoma (ACC) is a relatively rare tumor that accounts for <1% of all head and neck malignancies. Laryngeal localization of ACC, which is most commonly hypoglottic, is relatively rare, occurring in 0.07-0.25% of all laryngeal tumors. ACC is characterized as a slow-growing tumor with a high recurrence rate, which often causes dyspnea and hoarseness. ACC exhibits a propensity for perineural invasion and thus, patients may experience pain as a late symptom of the disease. Distant metastasis occurs in 35-50% of cases and the lungs are the most common site of metastasis. Tumors are usually diagnosed by physical examination with fiberoscopy and computed tomography of the neck and chest, due to the high rate of lung metastases. The standard therapy for ACC is surgery followed by radiotherapy. In this study, a 70-year-old patient presented with laryngeal ACC, who underwent total laryngectomy with bilateral neck dissection and adjuvant radiotherapy, is presented. Follow-up examination performed 2 years after surgery revealed no evidence of locoregional recurrence or distant metastases. Previously published literature regarding ACC of the larynx was also reviewed.

12.
Clin Respir J ; 12(2): 802-805, 2018 Feb.
Article in English | MEDLINE | ID: mdl-27461046

ABSTRACT

Herein, we described a novel method as the use of AcuBlade robotic microsurgery system to manage idiopathic subglottic stenosis in a 73-y-old lady. Compared to traditional CO2 lasers, AcuBlade facilitated the scar resection by the generation of different shape of beams (straight, curved, or disk). The same setting used for phonomicrosurgery (1-mm beam length, power of 10 W and pulse duration of 0.05-s) allowed to obtain fast, long, and uniform cuts. In addition, the reduction of the number of laser passes over the same area prevented injury of adjacent tissue and thus reduced the risk of recurrence.


Subject(s)
Laryngostenosis/diagnosis , Laryngostenosis/surgery , Lasers, Gas/therapeutic use , Microsurgery/instrumentation , Robotic Surgical Procedures/methods , Aged , Bronchoscopy/methods , Female , Follow-Up Studies , Humans , Laser Therapy/methods , Microsurgery/methods , Severity of Illness Index , Tomography, X-Ray Computed/methods , Treatment Outcome
13.
J Vasc Interv Radiol ; 28(3): 388-391, 2017 Mar.
Article in English | MEDLINE | ID: mdl-28034701

ABSTRACT

PURPOSE: To evaluate relationship between Meniere disease (MD) and chronic cerebrospinal venous insufficiency (CCSVI) using ultrasound, magnetic resonance (MR) imaging, and venography and to evaluate the effectiveness of angioplasty of the internal jugular vein (IJV) and azygos vein (AV) in reducing symptoms of MD. MATERIALS AND METHODS: Patients with a confirmed diagnosis of MD unresponsive to standard treatment underwent duplex ultrasound and MR imaging to diagnose CCSVI. Healthy volunteers were also studied to evaluate CCSVI in asymptomatic subjects. Patients with CCSVI and MD underwent venography and percutaneous transluminal angioplasty (PTA) of IJV and AV. RESULTS: There were 182 patients with no clinical benefit from standard treatments evaluated. CCSVI was diagnosed in 175 (87.5%) patients with MD. Venography was performed in 69 patients to confirm the diagnosis of CCSVI. In 80% of these patients, PTA of the IJV and/or AV was effective for treating signs and symptoms of MD. In the healthy cohort, CCSVI was observed in only 12% of subjects. CONCLUSIONS: These results suggest a possible etiologic relationship between CCSVI and MD that warrants further investigation.


Subject(s)
Angioplasty, Balloon , Azygos Vein , Cerebrovascular Disorders/therapy , Jugular Veins , Meniere Disease/therapy , Spinal Cord/blood supply , Venous Insufficiency/therapy , Adult , Aged , Azygos Vein/diagnostic imaging , Case-Control Studies , Cerebrovascular Disorders/diagnostic imaging , Cerebrovascular Disorders/epidemiology , Chronic Disease , Female , Humans , Italy/epidemiology , Jugular Veins/diagnostic imaging , Magnetic Resonance Angiography , Male , Meniere Disease/diagnostic imaging , Meniere Disease/epidemiology , Middle Aged , Phlebography/methods , Prevalence , Risk Factors , Time Factors , Treatment Outcome , Ultrasonography, Doppler, Duplex , Venous Insufficiency/diagnostic imaging , Venous Insufficiency/epidemiology
14.
J Cardiothorac Vasc Anesth ; 31(2): 441-445, 2017 Apr.
Article in English | MEDLINE | ID: mdl-27720495

ABSTRACT

OBJECTIVE: The authors assessed the diagnostic accuracy of a new modified Evans blue dye test (MEBDT) as a screening test for aspiration in tracheostomized patients. DESIGN: Monocentric retrospective study performed between October 2013 and December 2015. SETTING: Anesthesia and Intensive Care Unit, Second University of Naples. PARTICIPANTS: Among 62 eligible patients, 5 were excluded. The authors' study population included 57 patients. INTERVENTIONS: Patients underwent both fiberoptic endoscopic examination of the swallow (FEES) and MEBDT to evaluate swallow. The MEBDT results were compared with those of FEES and the diagnostic accuracy of MEBDT was calculated using the FEES as the gold standard. MEASUREMENTS AND MAIN RESULTS: The authors found that both FEES and MEBDT were positive for aspiration in 40 patients (true-positive MEBDT); FEES and MEBDT were negative in 10 (true-negative MEBDT). On the other hand, FEES was positive with an MEBDT negative in 7 patients (false-negative MEBDT), and there were no FEES negative and MEBDT positive (false-positive MEBDT). MEBDT had a sensitivity, specificity, positive, and negative predicted value of 85%, 100%, 100%, and 58.82%, respectively. CONCLUSIONS: MEBDT could be a supplementary diagnostic test for aspiration. Patients with positive MEBDT should not undergo oral feeding, while patients with negative MEBDT should undergo FEES before starting oral feeding.


Subject(s)
Endoscopy/methods , Evans Blue/administration & dosage , Fiber Optic Technology/methods , Mass Screening/methods , Respiratory Aspiration/diagnosis , Tracheostomy/adverse effects , Aged , Evans Blue/metabolism , Female , Humans , Male , Middle Aged , Respiratory Aspiration/metabolism , Retrospective Studies , Tracheostomy/trends
16.
Mol Clin Oncol ; 4(4): 467-471, 2016 Apr.
Article in English | MEDLINE | ID: mdl-27073643

ABSTRACT

Non-melanoma skin cancers (NMSCs) include a heterogeneous group of malignancies arising from the epidermis, comprising squamous cell carcinoma (SCC), basal cell carcinoma (BCC), Merkel cell carcinoma and more rare entities, including malignant pilomatrixoma and sebaceous gland tumours. The treatment of early disease depends primarily on surgery. In addition, certain patients present with extensive local invasion or metastasis, which renders these tumours surgically unresectable. Improving the outcome of radiotherapy through the use of concurrent systemic therapy has been demonstrated in several locally advanced cancer-treatment paradigms. Recently, agents targeting the human epidermal growth factor receptor (EGFR) have exhibited a consolidated activity in phase II clinical trials and case series reports. Cetuximab is a monoclonal antibody that binds to and completely inhibits the EGFR, which has been revealed to be up-regulated in a variety of SCCs, including NMSCs. The present review aimed to summarize the role of anti-EGFR agents in the predominant types of NMSC, including SCC and BCC, and focuses on the cetuximab-based studies, highlighting the biological rationale of this therapeutic option. In addition, the importance of the association between cetuximab and radiotherapy for locally advanced NMSC is discussed.

18.
Minerva Pediatr ; 68(4): 241-9, 2016 Aug.
Article in English | MEDLINE | ID: mdl-25393089

ABSTRACT

BACKGROUND: The aim of this study was to compare the effectiveness of a systemic steroid therapy vs. a thermal therapy based on sulphurous water insufflation. The therapy was performed in Telese Terme Spa based on the Salimbani-Politzer technique on children suffering of otitis media with effusion (OME), using the variations of the tympanogram as objective outcome in a short time follow-up. METHODS: Eighty children suffering of monolateral or bilateral OME (44 male, 36 female, age 4-12 years, average age 7.2±2.83 ys.), enrolled in ENT or paediatrics offices, have been included in the study. Children were included in a randomization list in order to obtain two therapeutic groups, the first one to be treated through a systemic steroid therapy, the second one to be treated through sulphuruos water insufflation in Telese Spa. Children underwent otoscopic/otomicroscopic visit and tympanometry before the beginning of the therapy (T0), 7 days after the beginning of the therapy (T1), 7-10 days after the end of the therapy (T2), 30-35 days after the end of the therapy (T3). The variation of the type of tympanogram was considered the objective outcome. The shift either from a type B to a type C or o type A tympanogram and from a type C to a type A tympanogram was considered a positive outcome; the persistence either of the same type of tympanogram and the shift from a type C to a type B or from a type A to a type C or a type B were considered a negative outcome. RESULTS: Thermal therapy showed better outcomes at each time, with differences in improvement and healing often reaching the statistical significance. The most important prognostic indicator was the presence of an initial type B tympanogram, associated to a worst prognosis in both therapeutic groups and in each subgroup of OME. CONCLUSIONS: Sulphurous water insufflation therapy appeared a good therapeutic choose in the treatment of OME in a pediatric population.


Subject(s)
Glucocorticoids/administration & dosage , Insufflation/methods , Otitis Media with Effusion/therapy , Sulfur/chemistry , Acoustic Impedance Tests , Child , Child, Preschool , Female , Humans , Male , Otitis Media with Effusion/physiopathology , Otoscopy , Prognosis , Time Factors , Treatment Outcome
19.
Otol Neurotol ; 36(2): 303-6, 2015 Feb.
Article in English | MEDLINE | ID: mdl-25569362

ABSTRACT

MAIN OBJECTIVE: To determine the utility of the hyperventilation test (HVT) in the diagnosis of vestibular schwannoma (VS). STUDY DESIGN: A retrospective analysis of hyperventilation-induced nystagmus (HVIN) in 45 patients with unilateral VS. SETTING: A tertiary referral center. PATIENTS: Forty-five patients with VS; 30 patients with chronic vestibular neuritis; 20 healthy subjects with normal hearing and without symptoms or a history of vertigo, migraine, or neurological diseases (control group). INTERVENTIONS: Audiological and vestibular examination; "side-stream" measurement of end-tidal CO2 pressure (P(EtCO2)) to standardize the procedure; magnetic resonance imaging (MRI) centered on the cerebellopontine angle. MAIN OUTCOME MEASURES: An analysis of HVIN, its patterns, and its appearance threshold via the measurement of P(EtCO2) correlations with the tumor size. RESULTS: HVIN was observed in 40 of 45 cases (88.9%) in the schwannoma group and in 12 of 30 cases (40%) in the chronic vestibular neuritis group; HVIN was not observed in the control group (0/20 cases) (p < 0.001). In the schwannoma group, HVIN was evoked at a mean P(EtCO2) value of 16.5 ± 1.15 mm Hg. The hypofunctional labyrinth was identified with high sensibility and specificity through caloric test, head shaking test, and head thrust test. The excitatory pattern, which included HVIN with slow phases that beat toward the hypofunctional side, and the paretic pattern, which included HVIN with slow phases that beat toward the hypofunctional side, were not significantly associated with VS size (19.04 ± 10.56 mm for the excitatory pattern and 19.06 ± 11.01 mm for the paretic pattern). The difference in the VS size in HVIN+ (19.05 ± 10.60 mm) and HVIN- (8.40 ± 2.19 mm) cases was significant (p = 0.009). CONCLUSIONS: A 60-second hyperventilation event causes metabolic changes in the vestibular system and reveals a latent vestibular asymmetry. The presence of an excitatory pattern is the major criterion that suggests VS in patients with signs of unilateral vestibular deficit.


Subject(s)
Hyperventilation/complications , Neuroma, Acoustic/diagnosis , Nystagmus, Pathologic/etiology , Vestibular Function Tests , Vestibular Neuronitis/diagnosis , Cerebellopontine Angle/pathology , Diagnosis, Differential , Humans , Hyperventilation/physiopathology , Magnetic Resonance Imaging , Neuroma, Acoustic/pathology , Neuroma, Acoustic/physiopathology , Nystagmus, Pathologic/physiopathology , Retrospective Studies , Vestibular Neuronitis/pathology , Vestibular Neuronitis/physiopathology
20.
Interact Cardiovasc Thorac Surg ; 18(3): 390-2, 2014 Mar.
Article in English | MEDLINE | ID: mdl-24327574

ABSTRACT

Airway stenting is the chosen treatment for patients affected by subglottic tracheal stenosis and unfit for surgery. Among the different types of prostheses, the Dumon stent is a valid option especially in patients without tracheotomy. Insertion is usually achieved by pushing the stent off from a loader using a prosthesis pusher. If the stent is expelled below the stenosis, rigid forceps grasping the proximal end of the stent retract it above the stenosis. However, in difficult cases such as rigid stenosis with a luminal diameter smaller than the profile of the stent, such a manoeuvre may be difficult in non-expert hands. Thus, we proposed a simple and safe technique to facilitate the placement of a Dumon stent. We passed a long thread from outside to the inside of the stent. After the dilatation of the stenosis, the stent was pushed and, if needed, easily retracted with the thread into the proper position to ensure airway patency and to avoid migration. In addition, our procedure could be useful also to rapidly remove the stent if its size turned out to be inaccurate for the stenosis. With such a simple method we successfully treated 7 consecutive patients affected by complex subglottic stenosis and unfit for surgery.


Subject(s)
Bronchoscopy/instrumentation , Bronchoscopy/methods , Stents , Tracheal Stenosis/therapy , Aged , Dilatation , Female , Humans , Male , Middle Aged , Prosthesis Design , Tracheal Stenosis/diagnosis , Tracheal Stenosis/physiopathology , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...